Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3

Journal of General Virology

Volumn 93, Issue 2, 2012, Pages

  Pasetto, Anna ^a,b   Frelin, Lars ^b   Brass, Anette ^b   Yasmeen, Anila ^a   Koh, Sarene ^b,c   Lohmann, Volker ^d   Bartenschlager, Ralf ^d   Magalhaes, Isabelle ^e   Maeurer, Markus ^e   Sällberg, Matti ^b   Chen, Margaret ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Department of Laboratory Medicine ^*  (Sweden)

^c AGENCY FOR SCIENCE   (Singapore)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A2 ANTIGEN; NONSTRUCTURAL PROTEIN 3; T LYMPHOCYTE RECEPTOR; VIRUS RNA; VIRUS VECTOR; LYMPHOCYTE ANTIGEN RECEPTOR; NS3 PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; DNA IMMUNIZATION; ELECTROPORATION; GENOTYPE; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; HYBRID CELL; HYBRIDOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPLICON; RNA REPLICATION; VIRAL CLEARANCE; ANIMAL; BLOOD DONOR; C57BL MOUSE; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; GENETICS; IMMUNOLOGY; TRANSGENIC MOUSE;

HEPATITIS C VIRUS; MURINAE; MUS MUSCULUS;

ANIMALS; BLOOD DONORS; CELLS, CULTURED; HEPACIVIRUS; HLA-A2 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84855954396     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.037903-0     Document Type: Article

References (49)

1. + T cell responses against soluble antigens in vivo. J Exp Med 202, 817- 828.
2. + T cells. J Immunol 179, 4741-4753
3. + T-cell memory using the yellow fever and smallpox vaccines. Immunol Cell Biol 89, 340-345
4. Alter, H. (2006). Viral hepatitis. Hepatology 43 (Suppl. 1), S230- S234.
5. + memory T cells. J Virol 82, 10017-10031
6. Bain, C., Fatmi, A., Zoulim, F., Zarski, J. P., Trépo, C. & Inchauspé, G. (2001). Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120, 512-524
7. Bartenschlager, R. & Sparacio, S. (2007). Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture. Virus Res 127, 195-207
8. Barth, H., Ulsenheimer, A., Pape, G. R., Diepolder, H. M., Hoffmann, M., Neumann-Haefelin, C., Thimme, R., Henneke, P., Klein, R. & other authors (2005). Uptake and presentation of hepatitis C virus-like particles by human dendritic cells. Blood 105, 3605-3614
9. Barth, H., Schnober, E. K., Neumann-Haefelin, C., Thumann, C., Zeisel, M. B., Diepolder, H. M., Hu, Z., Liang, T. J., Blum, H. E. & other authors (2008). Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. J Virol 82, 3466-3479
10. Brinster, C., Muguet, S., Lone, Y. C., Boucreux, D., Renard, N., Fournillier, A., Lemonnier, F. & Inchauspé, G. (2001). Differenthepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope. Hepatology 34, 1206-1217
11. + regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40, 1062-1071
12. Ciuffreda, D., Comte, D., Cavassini, M., Giostra, E., Bühler, L., Perruchoud, M., Heim, M. H., Battegay, M., Genné, D. & other authors (2008). Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur J Immunol 38, 2665-2677
13. + T cell responses during longitudinal study of acute human hepatitis C. Hepatology 42, 104-112
14. Cucchiarini, M., Kammer, A. R., Grabscheid, B., Diepolder, H. M., Gerlach, T. J., Grüner, N., Santantonio, T., Reichen, J., Pape, G. R. & Cerny, A. (2000). Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection. Cell Immunol 203, 111-123
15. Davis, J. L., Theoret, M. R., Zheng, Z., Lamers, C. H., Rosenberg, S. A. & Morgan, R. A. (2010). Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trials. Clin Cancer Res 16, 5852-5861
16. Diepolder, H.M., Zachoval, R., Hoffmann, R. M., Jung, M. C., Gerlach, T. & Pape, G. R. (1996). The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C. JMol Med (Berl) 74, 583-588.
17. Frelin, L., Alheim, M., Chen, A., Söderholm, J., Rozell, B., Barnfield, C., Liljeström, P. & Sällberg, M. (2003). Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNAbased vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo. Gene Ther 10, 686-699
18. Frelin, L., Ahlén, G., Alheim, M., Weiland, O., Barnfield, C., Liljeström, P. & Sällberg, M. (2004). Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene. Gene Ther 11, 522-533
19. Fytili, P., Dalekos, G. N., Schlaphoff, V., Suneetha, P. V., Sarrazin, C., Zauner, W., Zachou, K., Berg, T., Manns, M. P. & other authors (2008). Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073. Vaccine 26, 3818-3826
20. Goutagny, N., Fatmi, A., De Ledinghen, V., Penin, F., Couzigou, P., Inchauspé, G. & Bain, C. (2003). Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 187, 1951-1958
21. Himoudi, N., Abraham, J. D., Fournillier, A., Lone, Y. C., Joubert, A., Op De Beeck, A., Freida, D., Lemonnier, F., Kieny, M. P. & Inchauspé, G. (2002). Comparative vaccine studies in HLA-A2.1- transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection. J Virol 76, 12735-12746
22. Jäger, E., Höhn, H., Karbach, J., Momburg, F., Castelli, C., Knuth, A., Seliger, B. & Maeurer, M. J. (1999). Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A. Int J Cancer 81, 979-984
23. Kantzanou, M., Lucas, M., Barnes, E., Komatsu, H., Dusheiko, G., Ward, S., Harcourt, G. & Klenerman, P. (2003). Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers. Immunol Lett 85, 165-171
24. + T cell cross-reactivity in individuals infected with hepatitis C virus. J Clin Invest 118, 1143-1153
25. Kieback, E. & Uckert, W. (2010). Enhanced T cell receptor gene therapy for cancer. Expert Opin Biol Ther 10, 749-762
26. + T cells against exogenous viral antigens. Eur J Immunol 36, 2046-2060
27. Lechner, F., Gruener, N. H., Urbani, S., Uggeri, J., Santantonio, T., Kammer, A. R., Cerny, A., Phillips, R., Ferrari, C. & other authors (2000). CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 30, 2479-2487
28. McKee, M. D., Roszkowski, J. J. & Nishimura, M. I. (2005). T cell avidity and tumor recognition: implications and therapeutic strategies. J Transl Med 3, 35.
29. Miles, J. J., Thammanichanond, D., Moneer, S., Nivarthi, U. K., Kjer- Nielsen, L., Tracy, S. L., Aitken, C. K., Brennan, R. M., Zeng, W. & other authors (2011). Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection. J Immunol 186, 901-912
30. Nattermann, J., Zimmermann, H., Iwan, A., von Lilienfeld-Toal, M., Leifeld, L., Nischalke, H. D., Langhans, B., Sauerbruch, T. & Spengler, U. (2006). Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C. Hepatology 44, 945-954
31. Neveu, B., Debeaupuis, E., Echasserieau, K., le Moullac-Vaidye, B., Gassin, M., Jegou, L., Decalf, J., Albert, M., Ferry, N. & other authors (2008). Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection. Hepatology 48, 713-722
32. Pape, G. R., Gerlach, T. J., Diepolder, H. M., Grüner, N., Jung, M. & Santantonio, T. (1999). Role of the specific T-cell response for clearance and control of hepatitis C virus. J Viral Hepat 6 (Suppl. 1), 36-40
33. Pascolo, S., Bervas, N., Ure, J. M., Smith, A. G., Lemonnier, F. A. & Pérarnau, B. (1997). HLA-A2.1-restricted education and cytolytic activity of CD8+ T lymphocytes from b2 microglobulin (b2m) HLAA2.1 monochain transgenic H-2Db b2m double knockout mice. J Exp Med 185, 2043-2051
34. Radziewicz, H., Ibegbu, C. C., Fernandez, M. L., Workowski, K. A., Obideen, K., Wehbi, M., Hanson, H. L., Steinberg, J. P., Masopust, D. & other authors (2007). Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 81, 2545-2553
35. Rantala, M. & van de Laar, M. J. (2008). Surveillance and epidemiology of hepatitis B and C in Europe- a review. Euro Surveill 13, pii: 18880.
36. Rock, K. L., Rothstein, L. & Gamble, S. (1990). Generation of class I MHC-restricted T-T hybridomas. J Immunol 145, 804-811
37. Roszkowski, J. J., Yu, D. C., Rubinstein, M. P., McKee, M. D., Cole, D. J. & Nishimura, M. I. (2003). CD8-independent tumor cell recognition is a property of the T cell receptor and not the T cell. J Immunol 170, 2582-2589
38. Schulze zur Wiesch, J., Lauer, G. M., Day, C. L., Kim, A. Y., Ouchi, K., Duncan, J. E., Wurcel, A. G., Timm, J., Jones, A. M. & other authors (2005). Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol 175, 3603-3613
39. Söderholm, J., Ahlén, G., Kaul, A., Frelin, L., Alheim, M., Barnfield, C., Liljeström, P., Weiland, O., Milich, D. R. & other authors (2006Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut 55, 266-274
40. Sugimoto, K., Ikeda, F., Stadanlick, J., Nunes, F. A., Alter, H. J. & Chang, K. M. (2003). Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38, 1437-1448
41. Thompson, A. J. & McHutchison, J. G. (2009). Review article: investigational agents for chronic hepatitis C. Aliment Pharmacol Ther 29, 689-705
42. Turner, S. J., Doherty, P. C., McCluskey, J. & Rossjohn, J. (2006). Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol 6, 883-894
43. Ulsenheimer, A., Gerlach, J. T., Jung, M. C., Gruener, N., Wächtler, M., Backmund, M., Santantonio, T., Schraut, W., Heeg, M. H. & other authors (2005). Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. Hepatology 41, 643-651
44. Urbani, S., Amadei, B., Fisicaro, P., Pilli, M., Missale, G., Bertoletti, A. & Ferrari, C. (2005). Heterologous T cell immunity in severe hepatitis C virus infection. J Exp Med 201, 675-680
45. Wedemeyer, H., Mizukoshi, E., Davis, A. R., Bennink, J. R. & Rehermann, B. (2001). Cross-reactivity between hepatitis C virus and influenza A virus determinant-specific cytotoxic T cells. J Virol 75, 11392-11400
46. Wedemeyer, H., He, X. S., Nascimbeni, M., Davis, A. R., Greenberg, H. B., Hoofnagle, J. H., Liang, T. J., Alter, H. & Rehermann, B. (2002). Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169, 3447-3458
47. + T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology 37, 577-589
48. Wertheimer, A. M., Polyak, S. J., Leistikow, R. & Rosen, H. R. (2007). Engulfment of apoptotic cells expressing HCV proteins leads to differential chemokine expression and STAT signaling in human dendritic cells. Hepatology 45, 1422-1432
49. Zhang, Y., Liu, Y., Moxley, K. M., Golden-Mason, L., Hughes, M. G., Liu, T., Heemskerk, M. H., Rosen, H. R. & Nishimura, M. I. (2010). Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity. PLoS Pathog 6, e1001018.